Introduction
============

Hypertension is a global public-health challenge because of its high prevalence and driving role in stroke. Stroke has been a leading cause of death in recent years in China^[@bib1])^. The cerebrovascular remodeling induced by chronic hypertension promotes the development of stroke incidence. Although numerous established risk factors for hypertension and stroke have been highlighted, a particular genetic alteration or genotype combination and its interaction with environmental factors is also involved in the occurrence of cardiovascular diseases (CVDs)^[@bib2],\ [@bib3])^.

Abnormal vascular remodeling is a well-known risk factor for CVDs. The rho-associated kinase (ROCK) pathway regulates the intracellular actin cytoskeleton and initiates the remodeling of the vascular wall^[@bib4])^. *β*-actin (encoded by *ACTB* , a downstream effector of ROCK) is widely distributed in all eukaryotic cells and underlies cell migration^[@bib5],\ [@bib6])^. As an abundant and highly conserved cytoskeleton structural protein, *β*-actin helps organize and maintain the cellular morphology by virtue of facilitating the processes of migration, division, growth, signaling and shaping the cytoskeleton^[@bib7],\ [@bib8])^. Marina Karakozova, *et al.*^[@bib9])^ found that arginylation of *β*-actin regulated actin filament properties and lamella formation in motile cells. Animal experiments have confirmed that increased actin polymerization and stress fiber formation would generate mechanical force to trigger vascular hypertrophy and hypertension^[@bib10])^. *ACTB* gene hypomorphic mice died of uncharacterized development defects^[@bib11],\ [@bib12])^, reflecting the essential role of *ACTB* in maintaining routine intracellular biological functions. However, there is no population-based study investigates the association of *ACTB* with hypertension.

The actin cytoskeleton has been validated its pivotal position in neuronal development and activity^[@bib13])^. *β*-actin is also a signaling molecule. Studies have demonstrated that *β*-actin regulates endothelial nitric oxide synthase type 3 (eNOS-3) in platelets and vascular endothelial cells^[@bib14],\ [@bib15])^; these alterations probably contribute to vascular complications, atherosclerosis, and thrombotic diseases (such as ischemic stroke)^[@bib16])^. Furthermore, a whole-exome sequencing study in syndromic brain malformations identified a novel *de novo* mutation (p.Gly268Arg) in *ACTB*. Determining whether *ACTB* variations were associated with stroke incidence would warrant a population-based study.

Given the abovementioned evidences, we speculate that *β*-actin might participate in the mechanism of vascular remodeling and thrombogenesis and subsequently mediate the pathogenesis of hypertension and stroke. Notably, Rothenfluh *et al.* and Offenhäuser *et al.* found that the dynamic regulation of the actin cytoskeleton in flies and mice, respectively, affects cellular and behavioral sensitivity to alcohol^[@bib17],\ [@bib18])^. Further research would be required to explore whether alcohol exposure in the nervous system would modify the biological activities of actin cytoskeleton.

The present study aimed to evaluate whether the variants of *ACTB* contribute to the genetic susceptibility to hypertension and stroke and to evaluate the light of gene-environment interactions with mRNA transcriptional analysis. These would provide a novel insight into our improved understanding of the genetic role of *ACTB* in hypertension and stroke.

Methods
=======

Study Participants
------------------

In the case-control study, a total of 4,222 participants consisting of 2,012 hypertensive cases and 2,210 controls were drawn from the community hypertension survey (Yixing, Jiangsu Province, 2009)^[@bib19])^. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg or associated with patients who were then receiving anti-hypertensive medication, and patients who had a clinical history of secondary hypertension were excluded.

A total of 4,128 participants from the community hypertension survey in 2009 were enrolled. Flow charts of the case-control and follow-up studies are outlined in **[Supplementary Fig. 1](#F2){ref-type="fig"}**. During a median follow-up time of 5.01 years, 613 incident cases with hypertension and 183 incident cases with stroke including 171 ischemic stroke (IS) cases and 12 hemorrhagic stroke (HS) cases were recorded on a disease register and a report system. The demographic characteristics for follow-up study are displayed in **[Supplementary Table 1](#T5){ref-type="table"}**.

![The flow chart of the case-control and follow-up studies\
Inclusion of participants for evaluating the associations between *ACTB* and hypertension in the case-control study, and participants for the follow-up study. Matched elderly controls (*n* = 94) and 30 hypertension cases with history of stroke were excluded in the follow-up study.](jat-27-226-g002){#F2}

###### Demographic characteristics the follow-up study

  ---------------------------------------------------------------------------------------------
  Characteristics    Group    Follow-up study for hypertension\   Follow-up study for stroke\
                              *n* = 2116                          *n* = 4098
  ------------------ -------- ----------------------------------- -----------------------------
  Age (year)                  58.41 ± 10.28                       60.27 ± 10.67

  Gender (%)         Male     853 (40.31%)                        1660 (40.51%)

                     Female   1263 (59.69%)                       2438 (59.49%)

  BMI (kg/m^2^)               23.7 ± 3.21                         22.21 ± 3.38

  TC (mmol/L)                 4.78 ± 1.01                         4.85 ± 1.03

  TG (mmol/L)                 1.54 ± 1.21                         1.69 ± 1.41

  HDL-C (mmol/L)              1.37 ± 0.33                         1.37 ± 0.33

  LDL-C (mmol/L)              2.65 ± 0.72                         2.72 ± 0.81

  GLU (mmol/L)                5.47 ± 1.62                         5.65 ± 1.86

  Smokers (%)        Yes      525 (24.81%)                        995 (24.28%)

                     No       1591 (75.19%)                       3103 (75.72%)

  Drinkers (%)       Yes      468 (22.12%)                        883 (21.55%)

                     No       1648 (77.88%)                       3215 (78.45%)

  Hypertension (%)   Yes      \-                                  1985 (48.43%)

                     No       \-                                  2113 (51.56%)

  Diabetes (%)       T2DM     193 (9.12%)                         461 (11.98%)

                     IFG      418 (19.75%)                        891 (21.74%)

                     NGT      1505 (71.13%)                       2746 (66.28%)
  ---------------------------------------------------------------------------------------------

T2DM: type 2 diabetes mellitus; IFG: impaired fasting glucose; NGT: normal glucose tolerance

To access the disease status of subjects in the follow- up study, both concentrated and household surveys were conducted. Data collected from the local hospitals, centers for disease control and prevention (CDCs), community health service centers and a social security center were further inspected to reduce the information bias.

All participants were interviewed and underwent physical examinations and laboratory tests. The demographic characteristics of the participants were obtained by trained research staffs though a standard questionnaire, including data such as age, gender, smoking and drinking status. The weight, height and BP of the participants were measured as previously described^[@bib19])^.

Participants with a drinking habit were defined as those who currently or previously consumed alcoholic beverages at least 2 times per week for at least 6 months per year. A total of 901 subjects were identified with a drinking habit. The amount of alcoholic beverages that they consumed on a daily or weekly basis was divided into three categories: white spirits, beer and wine (assuming that the content of ethanol was 42% in white spirits, 3% in beer and 10% in wine). The amount of alcohol consumed was calculated in grams per day. According to the standard drink of 15 g of ethanol, participators were divided into the following categories: never, light-to-moderate (women: ≤ 1.0 drink/day; men: ≤ 2.0 drink/day) and heavy drinking group (women: \> 1.0 drink/day; men: \> 2.0 drink/day). Besides, daily or weekly alcohol consumption data for 104 individuals with a drinking habit were missing. We grouped these subjects into the light-to-moderate drinking group out of conservative considerations. Finally, 3,321, 369 and 532 subjects were categorized as non-drinking, light-to-moderate drinking and heavy drinking, respectively.

A nested case-control study was conducted to validate the observed interactive associations of single-nucleotide polymorphisms (SNPs) and drinking with stroke. A total of 24,352 subjects from a community-based epidemiological survey were recruited in Nantong city, Jiangsu Province from 2007 to 2008. Over a course of 9 years of follow-up, 860 incident stroke cases including 821 IS cases and 39 HS cases were identified according to the records from the local hospitals and CDCs. And 1,960 age- (5-year-old group) and gender-matched controls were enrolled for the analysis (**[Supplementary Table 2](#T6){ref-type="table"}**).

###### Demographic characteristics of the nested case-control study

  -------------------------------------------------------------------------------
  Characteristics    Group    Stroke\        Controls\       *t/χ*^2^   *P*
                              *n* = 860      *n* = 1960                 
  ------------------ -------- -------------- --------------- ---------- ---------
  Age (year)                  63.24 ± 7.24   61.78 ± 4.94    6.341      \<0.001

  Gender (%)         Male     353 (41.05%)   793 (40.46%)    0.085      0.77

                     Female   507 (58.95%)   1167 (59.54%)              

  BMI (kg/m^2^)               24.06 ± 3.85   23.64 ± 4.42    2.363      0.018

  TC (mmol/L)                 4.32 ± 1.64    4.24 ± 0.92     1.545      0.122

  TG (mmol/L)                 1.63 ± 1.54    1.51 ± 1.38     2.076      0.038

  HDL-C (mmol/L)              1.57 ± 0.41    1.63 ± 0.43     3.534      \<0.001

  LDL-C (mmol/L)              2.08 ± 1.56    1.99 ± 0.72     2.057      0.04

  GLU (mmol/L)                5.01 ± 2.61    5.51 ± 3.10     3.941      \<0.001

  Smokers (%)        Yes      213 (24.77%)   445 (22.70%)    1.325      0.25

                     No       647 (75.23%)   1515 (77.30%)              

  Drinkers (%)       Yes      229 (26.63%)   583 (29.74%)    2.894      0.089

                     No       631 (73.37%)   1377 (70.26%)              

  Hypertension (%)   Yes      446 (51.86%)   701 (35.76%)    64.17      \<0.001

                     No       414 (48.14%)   1259 (64.24%)              

  Diabetes (%)       T2DM     99 (11.51%)    466 (23.77%)    70.727     \<0.001

                     IFG      26 (3.02%)     110 (5.61%)                

                     NGT      735 (85.47%)   1384 (70.62%)              
  -------------------------------------------------------------------------------

T2DM: type 2 diabetes mellitus; IFG: impaired fasting glucose; NGT: normal glucose tolerance

The study was approved by the ethics committee of Nanjing Medical University and conducted according to the principles of the Declaration of Helsinki. The written informed consent was obtained from all subjects during epidemiological interviews.

SNP Selection
-------------

The *ACTB* gene locates on chromosome 7p22.1 (Gene ID: 60; NC_000007.14), spans 3.4 kbps and contains 6 exons. We searched the SNP-covered *ACTB* gene from the upstream 5 kb to the downstream 2 kb and selected tagging SNPs (tagSNPs) from the database of the Chinese Han population in Beijing, China of the International Hap MAP Project (HapMap Data Rel 24/phase II Nov08, on NCBI B36 assembly, dbSNPb126). All tagSNPs were selected with a minor allele frequency (MAF) ≥ 0.05 and linkage disequilibrium (LD) r^2^ ≥ 0.8. We also applied a functional candidate strategy to select potential functional SNPs on the bioinformatics effect prediction website (SNPINFO, <https://snpinfo.niehs.nih.gov/>). Finally, rs852426 (T\>C), rs852423 (A\>G), and rs2966449 (T\>C) were selected, and their specific biological information was summarized in **[Supplementary Table 3](#T7){ref-type="table"}**.

###### The biological information and function prediction of three tagSNPs of *ACTB* gene

  No   SNP         Chromosome   Position   Allele   LDsnp       Pop/LD   TFBS    RegPotential   Conservation   Nearby Gene       Distance (bp)
  ---- ----------- ------------ ---------- -------- ----------- -------- ------- -------------- -------------- ----------------- -----------------
  1    rs852426    7            5532879    T/C      rs852426    1        \--     0              0.002          MIRN589\|\|ACTB   −30806\|\|−433
  2    rs852423    7            5534892    A/G      rs852423    1        \--     0.266          0              ACTB              1580\|\|1855
  3    rs2966449   7            5538151    T/C      rs2966449   1        Msx-1   0.135          0              ACTB\|\|FSCN1     −1404\|\|−60829

TFBS, transcription factor binding site; RegPotential, regulatory potential score.

Blood Sampling and SNP Genotyping
---------------------------------

Blood samples were donated by participants for genotyping with adding ethylenediamine tetraacetic acid (EDTA)-containing receptacles. After an over-night fasting (\>10 h), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and glucose (GLU) were measured. DNA was extracted using a standard phenole-chloroform method and stored at −20°C. Genotyping was performed using the TaqMan allelic discrimination assay in 384-well plates on the platform of 7900HT realtime polymerase chain reaction (PCR) system (Applied Biosystems, Foster City, CA). The primers and probes were designed using Primer Express Oligo Design software ver. 2.0 (ABI PRISM). Genotyping results were determined using SDS 2.3 Allelic Discrimination Software (Applied Biosystems). Meanwhile, each plate included blank samples as negative controls for the genotyping quality confirmation. The successful call rates of SNPs rs852426, rs852423 and rs2966449 were 99.90%, 99.95% and 99.92%, respectively.

Determination of *ACTB* mRNA
----------------------------

The expression of *ACTB* mRNA (NCBI Reference Sequence: NM_001101.4) in peripheral blood mononuclear cells (PBMCs) was measured between IS cases and age- and gender- matched controls (72 vs. 72). All IS cases were enrolled from the People\'s Hospital of Yixing City, Department of Neurology.

Total RNA was isolated from PBMCs (100 µl) using an RNA blood kit (Cat\#Yu-B02-1, Yuan Corp., Wuxi, China) according to the manual instructions. A total of 7.5 µl RNA was used for cDNA reversion. cDNA was synthesized using TAKARA reverse transcription kits (RR047A Takara PrimeScript™ RT reagent kit with gDNA Eraser, Japan). The primers used were designed by using Primer Premier 5.0 software, and the primer sequences were listed as follows: forward (5′-3′), TGACGTGGACATCCGCAAAG and reversed (5′-3′), CTGGAAGGTGGACAGCGAGG.

Quantitative real-time PCR (qPCR) was processed in a final volume of 10 µl (2 µl cDNA, 5 µl HieffTM qPCR SYBR^®^ GEEN Master Mix, 0.2 µl of each primer and 5 µl RNase-free water) running in triplicate using the ABI RT-PCR 7900 system (Applied Biosystems; Thermo Fisher Scientific, Inc.). Using the glyceraldehyde phosphate dehydrogenase (*GAPDH*) gene as internal control, amplification of the *ACTB* gene was performed in the same tube under following thermal cycling conditions: initial denaturation at 95°C for 5 min, 95°C for 10 s, 60°C for 20 s and 72°C for 20 s, 95°C for 15 s, 60°C for 1 min and then 95°C for 15 s with 40 cycles. Melting curve includes one cycle with 95°C for 15 s, 60°C for 1 min and 95°C for 15 s. The standard deviation (*SD*) of cycle threshold (CT) values among each duplicate sample was less than 0.5. The expression of *ACTB* mRNA was calculated with the 2^−ΔΔCT^ method.

Statistical Analysis
--------------------

Unpaired Student\'s *t*-test was used to test the differences in all the quantitative variables among groups presented as mean ± SD. The Hardy−Weinberg equilibrium (HWE) for genotype frequencies was estimated with a Fisher\'s exact test in controls. Chi-square (*χ*^2^) test was performed to compare the allele and genotype frequency distributions. Multiple unconditional logistic regression analyses were applied to evaluate the genetic effects of screened SNPs on hypertension by calculating the odds ratio (OR) and its 95% confidence interval (CI). Cox regression was applied to estimate hazard ratios (HRs) and 95% CI in the follow-up study. The interaction of drinking and *ACTB* polymorphisms with stroke incidence was estimated. The additive interaction was displayed by calculating the relative excess risk due to interaction (RERI), attributable proportion (AP) due to interaction and synergy index (SI)^[@bib20])^. The multiplicative interaction hazard ratio was calculated by fitting the Cox regression model. Stratification analyses by gender, age group, smoking and drinking status were further conducted in both case-control and follow-up studies. A logistic regression model was used to evaluate the genetic effects of SNPs on stroke for the nested case-control study. A two-tailed *p* value of 0.05 was defined as statistical significance. All statistical analyses were performed with SPSS version 25.0 (SPSS, Inc., Chicago, IL).

Results
=======

Demographic Characteristics at Baseline
---------------------------------------

The demographic characteristics of participants were summarized in **[Table 1](#T1){ref-type="table"}**. The hypertensive cases were average 3.42 years older than the controls (*p* \< 0.001), although an age-matched (5 years) method was used for the analysis. Subjects with hypertension had higher levels of BMI, TC, TG, LDL-C and GLU than those of controls (*p* \< 0.001), whereas no significant differences in gender, HDL-C, smoking status and drinking status were observed (*p* \> 0.05). Overall, these characteristics were adjusted as confounding factors to evaluate the association of *ACTB* with hypertension.

###### Demographic and clinical characteristics of the hypertension case-control study

  ---------------------------------------------------------------------------------
  Characteristics   Group    Hypertension\    Normotension\    *t/χ^2^*   *p*
                             *n* = 2,012      *n* = 2,210                 
  ----------------- -------- ---------------- ---------------- ---------- ---------
  Age (year)                 62.35 ± 10.73    58.93 ± 10.45    10.484     \<0.001

  Gender (%)        Male     829 (41.20)      884 (40.00)      0.632      0.427

                    Female   1,183 (58.80)    1,326 (60.00)               

  SBP (mm Hg)                142.86 ± 14.30   124.24 ± 11.36   47.018     \<0.001

  DBP (mm Hg)                87.53 ± 8.54     79.08 ± 6.51     36.369     \<0.001

  BMI (kg/m^2^)              24.76 ± 3.51     23.64 ± 3.20     10.844     \<0.001

  TC (mmol/L)                4.94 ± 1.05      4.78 ± 1.01      4.574      \<0.001

  TG (mmol/L)                1.86 ± 1.58      1.53 ± 1.21      7.618      \<0.001

  HDL-C (mmol/L)             1.36 ± 0.33      1.36 ± 0.33      0.175      0.751

  LDL-C (mmol/L)             2.80 ± 0.89      2.64 ± 0.73      6.227      \<0.001

  GLU (mmol/L)               5.83 ± 2.05      5.46 ± 1.61      6.684      \<0.001

  Smokers (%)       Yes      480 (23.86)      533 (24.12)      0.039      0.843

                    No       1,532 (76.14)    1,677 (75.88)               

  Drinkers (%)      Yes      424 (21.07)      477 (21.58)      0.163      0.686

                    No       1,588 (78.93)    1,733 (78.42)               
  ---------------------------------------------------------------------------------

BMI, body mass index; DBP, diastolic blood pressure; GLU, glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.

Association Analysis for the Case-Control Study of Hypertension
---------------------------------------------------------------

The distributions of rs852426, rs852423 and rs2966449 in controls were consistent with *HWE* (*p* \>0.05). No significant associations were observed between each of the three SNPs and hypertension in the whole population (**[Supplementary Table 4](#T8){ref-type="table"}**). Stratification analysis by drinking status indicated that drinkers with the rs852426 CC genotype had a higher risk of hypertension than that of TT/TC carriers; after adjustment for age, gender, BMI, GLU, HDL-C, LDL-C, TC, TG and smoking status, the OR (95% CI) was 1.971 (1.053−3.691) with a *p* value of 0.034 (**[Supplementary Table 5](#T9){ref-type="table"}**). However, the associations mentioned above were not statistically significant after Bonferroni correction.

###### Association analyses of *ACTB* with hypertension in the case-control study

  SNP         Group     WT/HT/MT       *OR (95% CI)*^[a](#tf3){ref-type="table-fn"}^   Allele gene                                                                      
  ----------- --------- -------------- ----------------------------------------------- ---------------------- ---------------------- ----------- ---------------------- -------
  rs852426              TT/TC/CC                                                                                                     T/C                                
              Case      1217/696/99    1.036 (0.929--1.156)                            1.006 (0.884--1.144)   1.282 (0.944--1.740)   3130/894    0.963 (0.869--1.068)   0.478
              Control   1342/776/88    *P* = 0.521                                     *P* = 0.930            *P* = 0.112            3460/952    *P* = 0.239            
  rs852423              AA/AG/GG                                                                                                     A/G                                
              Case      993/809/209    1.040 (0.946--1.144)                            1.049 (0.925--1.190)   1.063 (0.863--1.309)   2795/1227   0.961 (0.874--1.056)   0.406
              Control   1119/869/221   *P* = 0.413                                     *P* = 0.457            *P* = 0.568            3107/1311   *P* = 0.235            
  rs2966449             TT/TC/CC                                                                                                     T/C                                
              Case      1135/763/114   0.973 (0.877--1.080)                            0.975 (0.858--1.107)   0.933 (0.713--1.220)   3033/991    1.005 (0.910--1.110)   0.924
              Control   1250/823/134   *P* = 0.606                                     *P* = 0.696            *P* = 0.612            3323/1091   *P* = 0.462            

WT, wild type, HT, heterozygote, MT, mutant type.

Adjusted for age, gender, body mass index (BMI), glucose (GLU), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglyceride (TG), smoking and drinking status.

*P* value of *χ*^2^ test for comparison of allele frequencies between hypertension case and control groups.

*P* value of *χ*^2^ test for comparison of genotype between hypertension case and control groups.

The unsuccessful genotyped number of rs852426, rs852423 and rs2966449 was 4, 2 and 3, respectively.

###### Stratification analysis by age, gender, smoking and drinking status for the association of *ACTB* with hypertension in the case-control study

  SNP         Stratum        Group     WT/HT/MT      *OR (95% CI)*                                                                                                 
  ----------- -------------- --------- ------------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  rs852426                             TT/TC/CC                                                                                                                    
              Male           Case      509/273/47    0.957 (0.810--1.129)^[a](#tf6){ref-type="table-fn"}^   0.892 (0.729--1.090)^[a](#tf6){ref-type="table-fn"}^   1.275 (0.818--1.986)^[a](#tf6){ref-type="table-fn"}^
                             Control   527/316/41    *P* = 0.601                                            *P* = 0.263                                            *P* = 0.284
              Female         Case      708/423/52    1.115 (0.964--1.289)^[a](#tf6){ref-type="table-fn"}^   1.110 (0.937--1.315)^[a](#tf6){ref-type="table-fn"}^   1.316 (0.862--2.009)^[a](#tf6){ref-type="table-fn"}^
                             Control   815/460/47    *P* = 0.141                                            *P* = 0.227                                            *P* = 0.204
              \<55 years     Case      339/172/23    0.931 (0.765--1.135)^[b](#tf7){ref-type="table-fn"}^   0.897 (0.711--1.130)^[b](#tf7){ref-type="table-fn"}^   1.067 (0.610--1.868)^[b](#tf7){ref-type="table-fn"}^
                             Control   521/302/34    *P* = 0.481                                            *P* = 0.356                                            *P* = 0.820
              ≥ 55 years     Case      878/524/76    1.089 (0.955--1.243)^[b](#tf7){ref-type="table-fn"}^   1.063 (0.910--1.243)^[b](#tf7){ref-type="table-fn"}^   1.387 (0.959--2.008)^[b](#tf7){ref-type="table-fn"}^
                             Control   821/474/54    *P* = 0.202                                            *P* = 0.441                                            *P* = 0.083
              Smoking        Case      295/161/24    1.010 (0.805--1.267)^[c](#tf8){ref-type="table-fn"}^   0.931 (0.713--1.217)^[c](#tf8){ref-type="table-fn"}^   1.633 (0.854--3.123)^[c](#tf8){ref-type="table-fn"}^
                             Control   324/191/18    *P* = 0.932                                            *P* = 0.603                                            *P* = 0.138
              Non-smoking    Case      922/535/75    1.046 (0.924--1.185)^[c](#tf8){ref-type="table-fn"}^   1.030 (0.888--1.194)^[c](#tf8){ref-type="table-fn"}^   1.209 (0.854--1.711)^[c](#tf8){ref-type="table-fn"}^
                             Control   1018/585/70   *P* = 0.475                                            *P* = 0.695                                            *P* = 0.285
              Drinking       Case      256/141/27    1.098 (0.871--1.385)^[d](#tf9){ref-type="table-fn"}^   0.997 (0.753--1.322)^[d](#tf9){ref-type="table-fn"}^   1.971 (1.053--3.691)^[d](#tf9){ref-type="table-fn"}^
                             Control   287/171/19    *P* = 0.429                                            *P* = 0.985                                            *P* = 0.034
              Non-drinking   Case      961/555/72    1.026 (0.906--1.161)^[d](#tf9){ref-type="table-fn"}^   1.014 (0.877--1.174)^[d](#tf9){ref-type="table-fn"}^   1.132 (0.796--1.612)^[d](#tf9){ref-type="table-fn"}^
                             Control   1055/605/69   *P* = 0.685                                            *P* = 0.847                                            *P* = 0.490
  rs852423                             AA/AG/GG                                                                                                                    
              Male           Case      410/330/88    0.999 (0.863--1.156)^[a](#tf6){ref-type="table-fn"}^   0.974 (0.800--1.185)^[a](#tf6){ref-type="table-fn"}^   1.066 (0.776--1.465)^[a](#tf6){ref-type="table-fn"}^
                             Control   439/351/94    *P* = 0.986                                            *P* = 0.790                                            *P* = 0.694
              Female         Case      583/479/121   1.079 (0.952--1.223)^[a](#tf6){ref-type="table-fn"}^   1.116 (0.946--1.316)^[a](#tf6){ref-type="table-fn"}^   1.069 (0.810--1.412)^[a](#tf6){ref-type="table-fn"}^
                             Control   680/518/127   *P* = 0.233                                            *P* = 0.195                                            *P* = 0.636
              \<55 years     Case      266/219/48    1.000 (0.842--1.187)^[b](#tf7){ref-type="table-fn"}^   1.022 (0.816--1.280)^[b](#tf7){ref-type="table-fn"}^   0.936 (0.635--1.380)^[b](#tf7){ref-type="table-fn"}^
                             Control   434/339/84    *P* = 0.998                                            *P* = 0.849                                            *P* = 0.740
              ≥ 55 years     Case      727/590/161   1.062 (0.948--1.191)^[b](#tf7){ref-type="table-fn"}^   1.066 (0.915--1.242)^[b](#tf7){ref-type="table-fn"}^   1.127 (0.878--1.447)^[b](#tf7){ref-type="table-fn"}^
                             Control   685/530/137   *P* = 0.298                                            *P* = 0.413                                            *P* = 0.349
              Smoking        Case      237/192/50    1.057 (0.869--1.285)^[c](#tf8){ref-type="table-fn"}^   1.012 (0.780--1.312)^[c](#tf8){ref-type="table-fn"}^   1.271 (0.824--1.960)^[c](#tf8){ref-type="table-fn"}^
                             Control   272/211/50    *P* = 0.579                                            *P* = 0.930                                            *P* = 0.278
              Non-smoking    Case      756/617/159   1.037 (0.930--1.156)^[c](#tf8){ref-type="table-fn"}^   1.059 (0.916--1.223)^[c](#tf8){ref-type="table-fn"}^   1.020 (0.804--1.295)^[c](#tf8){ref-type="table-fn"}^
                             Control   847/658/171   *P* = 0.514                                            *P* = 0.441                                            *P* = 0.870
              Drinking       Case      201/174/48    1.112 (0.906--1.364)^[d](#tf9){ref-type="table-fn"}^   1.102 (0.837--1.452)^[d](#tf9){ref-type="table-fn"}^   1.276 (0.822--1.981)^[d](#tf9){ref-type="table-fn"}^
                             Control   235/192/50    *P* = 0.309                                            *P* = 0.489                                            *P* = 0.277
              Non-drinking   Case      792/635/161   1.027 (0.923--1.144)^[d](#tf9){ref-type="table-fn"}^   1.043 (0.904--1.202)^[d](#tf9){ref-type="table-fn"}^   1.017 (0.801--1.290)^[d](#tf9){ref-type="table-fn"}^
                             Control   884/677/171   *P* = 0.622                                            *P* = 0.567                                            *P* = 0.892
  rs2966449                            TT/TC/CC                                                                                                                    
              Male           Case      471/313/45    0.916 (0.779--1.076)^[a](#tf6){ref-type="table-fn"}^   0.921 (0.755--1.122)^[a](#tf6){ref-type="table-fn"}^   0.805 (0.531--1.220)^[a](#tf6){ref-type="table-fn"}^
                             Control   489/336/58    *P* = 0.285                                            *P* = 0.412                                            *P* = 0.306
              Female         Case      664/450/69    1.018 (0.888--1.167)^[a](#tf6){ref-type="table-fn"}^   1.017 (0.861--1.202)^[a](#tf6){ref-type="table-fn"}^   1.042 (0.731--1.484)^[a](#tf6){ref-type="table-fn"}^
                             Control   761/487/76    *P* = 0.800                                            *P* = 0.840                                            *P* = 0.820
              \<55 years     Case      318/186/30    0.917 (0.760--1.106)^[b](#tf7){ref-type="table-fn"}^   0.871 (0.694--1.094)^[b](#tf7){ref-type="table-fn"}^   1.046 (0.644--1.697)^[b](#tf7){ref-type="table-fn"}^
                             Control   483/324/48    *P* = 0.364                                            *P* = 0.234                                            *P* = 0.856
              ≥ 55 years     Case      817/577/84    0.988 (0.870--1.121)^[b](#tf7){ref-type="table-fn"}^   1.031 (0.883--1.203)^[b](#tf7){ref-type="table-fn"}^   0.894 (0.648--1.235)^[b](#tf7){ref-type="table-fn"}^
                             Control   767/499/86    *P* = 0.846                                            *P* = 0.701                                            *P* = 0.498
              Smoking        Case      269/188/23    1.010 (0.811--1.257)^[c](#tf8){ref-type="table-fn"}^   1.016 (0.782--1.320)^[c](#tf8){ref-type="table-fn"}^   0.987 (0.544--1.791)^[c](#tf8){ref-type="table-fn"}^
                             Control   298/207/27    *P* = 0.931                                            *P* = 0.903                                            *P* = 0.966
              Non-smoking    Case      866/575/91    0.964 (0.856--1.085)^[c](#tf8){ref-type="table-fn"}^   0.962 (0.831--1.113)^[c](#tf8){ref-type="table-fn"}^   0.930 (0.688--1.257)^[c](#tf8){ref-type="table-fn"}^
                             Control   952/616/107   *P* = 0.544                                            *P* = 0.603                                            *P* = 0.639
              Drinking       Case      231/167/26    1.022 (0.817--1.279)^[d](#tf9){ref-type="table-fn"}^   1.027 (0.780--1.354)^[d](#tf9){ref-type="table-fn"}^   1.027 (0.584--1.807)^[d](#tf9){ref-type="table-fn"}^
                             Control   263/183/31    *P* = 0.847                                            *P* = 0.848                                            *P* = 0.925
              Non-drinking   Case      904/596/88    0.966 (0.858--1.087)^[d](#tf9){ref-type="table-fn"}^   0.963 (0.834--1.112)^[d](#tf9){ref-type="table-fn"}^   0.938 (0.690--1.275)^[d](#tf9){ref-type="table-fn"}^
                             Control   987/640/103   *P* = 0.561                                            *P* = 0.605                                            *P* = 0.683

Adjusted for age, BMI, glucose, HDL-C, LDL-C, TC, TG, smoking and drinking status.

Adjusted for gender, BMI, glucose, HDL-C, LDL-C, TC, TG, smoking and drinking status.

Adjusted for age, gender, BMI, glucose, HDL-C, LDL-C, TC, TG and drinking status.

Adjusted for age, gender, BMI, glucose, HDL-C, LDL-C, TC, TG and smoking status.

Association Analysis for the Follow-Up Study
--------------------------------------------

The incidences density for hypertension and stroke were 681.85/10^4^ person-years and 86.55/10^4^ person-years, respectively. No significant associations were observed between the SNPs and hypertension, nor was stroke incidence in the whole population (**[Supplementary Table 6](#T10){ref-type="table"}**). A further stratification analysis by gender, age, smoking status and drinking status was conducted (**[Supplementary Table 7](#T11){ref-type="table"}**). Males with rs852423 AG/GG genotypes had a higher incidence of hypertension compared to AA genotype carriers; after being adjusted for covariates, HR (95% CI) was 1.334 (1.044−1.705), with *p* = 0.021. In females, individuals with the rs852423 GG genotype presented a higher risk of hypertension when compared with AA/AG carriers, the HR (95% CI) was 1.466 (1.038−2.068), *p* = 0.030. In the \<55 years age group, the rs852423 variation increased the risk of hypertension (*p* = 0.043), and the adjusted HR (95% CI) was 1.261 (1.008−1.578). In the drinking subpopulation, rs852426 T\>C variation had a significant protective effect on stroke, and the adjusted HR (95% CI) was 0.470 (0.227−0.975), with a *p* value of 0.042 (**[Table 2](#T2){ref-type="table"}**). These results were not valid after Bonferroni correction.

###### Association analyses of *ACTB* with hypertension and stroke in the follow-up study

  End Point      SNP         Genotype   N     Person-years   Incidence density (/10^4^ Person-years)   *HR (95% CI)*                                                                                                        
  -------------- ----------- ---------- ----- -------------- ----------------------------------------- ------------------------------------------------------------ ------------------------------------------------------- -------------------------------------------------------
  Hypertension   rs852426    TT         357   5471.94        652.42                                    1.129 (0.984--1.297)^[a](#tf10){ref-type="table-fn"}^        1.167 (0.992--1.372)^[a](#tf10){ref-type="table-fn"}^   1.073 (0.712--1.619)^[a](#tf10){ref-type="table-fn"}^
                             TC         232   3170.40        731.77                                    *P* = 0.085                                                  *P* = 0.063                                             *P* = 0.735
                             CC         24    346.59         692.46                                                                                                                                                         
                 rs852423    AA         290   4526.55        640.66                                    1.120 (0.993--1.265)^[a](#tf10){ref-type="table-fn"}^        1.157 (0.986--1.357)^[a](#tf10){ref-type="table-fn"}^   1.154 (0.880--1.513)^[a](#tf10){ref-type="table-fn"}^
                             AG         262   3587.49        730.32                                    *P* = 0.066                                                  *P* = 0.073                                             *P* = 0.299
                             GG         59    874.90         674.36                                                                                                                                                         
                 rs2966449   TT         338   5043.27        670.20                                    1.039 (0.911--1.186)^[a](#tf10){ref-type="table-fn"}^        1.075 (0.916--1.262)^[a](#tf10){ref-type="table-fn"}^   0.923 (0.642--1.327)^[a](#tf10){ref-type="table-fn"}^
                             TC         244   3396.07        718.48                                    *P* = 0.568                                                  *P* = 0.374                                             *P* = 0.665
                             CC         31    546.53         567.21                                                                                                                                                         
  Stroke         rs852426    TT         106   12895.59       82.20                                     1.059 (0.821--1.366)^[b](#tf11){ref-type="table-fn"}^        1.074 (0.795--1.450)^[b](#tf11){ref-type="table-fn"}^   1.052 (0.514--2.151)^[b](#tf11){ref-type="table-fn"}^
                             TC         69    7341.14        93.99                                     *P* = 0.658                                                  *P* = 0.644                                             *P* = 0.890
                             CC         8     905.11         88.39                                                                                                                                                          
                 rs852423    AA         83    106            63.54                                     77.841.170 (0.941--1.455)^[b](#tf11){ref-type="table-fn"}^   1.289 (0.958--1.735)^[b](#tf11){ref-type="table-fn"}^   1.080 (0.662--1.764)^[b](#tf11){ref-type="table-fn"}^
                             AG         82    8366.72        98.01                                     *P* = 0.157                                                  *P* = 0.093                                             *P* = 0.757
                             GG         18    2105.38        85.50                                                                                                                                                          
                 rs2966449   TT         98    11952.30       81.99                                     1.014 (0.793--1.298)^[b](#tf11){ref-type="table-fn"}^        1.064 (0.791--1.432)^[b](#tf11){ref-type="table-fn"}^   0.801 (0.391--1.640)^[b](#tf11){ref-type="table-fn"}^
                             TC         77    7943.78        96.93                                     *P* = 0.910                                                  *P* = 0.680                                             *P* = 0.544
                             CC         8     1239.61        64.54                                                                                                                                                          

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, drinking status and T2DM.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, drinking status, T2DM and hypertension.

###### Stratification analysis by age, gender, smoking and drinking status for the association of *ACTB* with hypertension and stroke in the follow-up study

  End Point      SNP         Stratum        Genotype   N     Person-years   Incidence density (/10^4^ Person-years)   *HR* (95% *CI*)                                                                                                 
  -------------- ----------- -------------- ---------- ----- -------------- ----------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  Hypertension   rs852426    Male           TT         150   2154.16        696.33                                    1.106 (0.899--1.361)^[a](#tf12){ref-type="table-fn"}^   1.204 (0.940--1.542)^[a](#tf12){ref-type="table-fn"}^   0.754 (0.384--1.481)^[a](#tf12){ref-type="table-fn"}^
                                            TC         107   1269.52        842.84                                    *P* = 0.341                                             *P* = 0.142                                             *P* = 0.413
                                            CC         9     159.13         565.58                                                                                                                                                    
                             Female         TT         207   3317.79        623.91                                    1.172 (0.969--1.418)^[a](#tf12){ref-type="table-fn"}^   1.148 (0.924--1.426)^[a](#tf12){ref-type="table-fn"}^   1.599 (0.942--2.714)^[a](#tf12){ref-type="table-fn"}^
                                            TC         125   1900.87        657.59                                    *P* = 0.101                                             *P* = 0.214                                             *P* = 0.082
                                            CC         15    187.45         800.21                                                                                                                                                    
                             \<55 years     TT         105   2225.96        471.71                                    1.120 (0.872--1.438)^[a](#tf12){ref-type="table-fn"}^   1.169 (0.868--1.575)^[a](#tf12){ref-type="table-fn"}^   1.011 (0.491--2.085)^[a](#tf12){ref-type="table-fn"}^
                                            TC         70    1331.86        525.58                                    *P* = 0.376                                             *P* = 0.304                                             *P* = 0.975
                                            CC         8     157.06         509.36                                                                                                                                                    
                             ≥ 55 years     TT         252   3245.98        776.34                                    1.166 (0.986--1.378)^[a](#tf12){ref-type="table-fn"}^   1.201 (0.989--1.459)^[b](#tf13){ref-type="table-fn"}^   1.158 (0.700--1.914)^[b](#tf13){ref-type="table-fn"}^
                                            TC         162   1838.53        881.14                                    *P* = 0.072                                             *P* = 0.065                                             *P* = 0.568
                                            CC         16    189.53         844.19                                                                                                                                                    
                             Smoking        TT         85    1364.35        623.01                                    1.127 (0.856--1.485)^[c](#tf14){ref-type="table-fn"}^   1.248 (0.902--1.726)^[c](#tf14){ref-type="table-fn"}^   0.636 (0.231--1.751)^[c](#tf14){ref-type="table-fn"}^
                                            TC         70    787.22         889.21                                    *P* = 0.394                                             *P* = 0.181                                             *P* = 0.381
                                            CC         4     83.65          478.18                                                                                                                                                    
                             Non-smoking    TT         272   4107.6         662.19                                    1.102 (0.935--1.299)^[c](#tf14){ref-type="table-fn"}^   1.090 (0.901--1.319)^[c](#tf14){ref-type="table-fn"}^   1.312 (0.833--2.065)^[c](#tf14){ref-type="table-fn"}^
                                            TC         162   2383.18        679.76                                    *P* = 0.245                                             *P* = 0.373                                             *P* = 0.241
                                            CC         20    262.94         760.63                                                                                                                                                    
                             Drinking       TT         86    1193.82        720.38                                    1.130 (0.854--1.496)^[d](#tf15){ref-type="table-fn"}^   1.214 (0.870--1.693)^[d](#tf15){ref-type="table-fn"}^   0.872 (0.375--2.025)^[d](#tf15){ref-type="table-fn"}^
                                            TC         63    709.91         887.44                                    *P* = 0.392                                             *P* = 0.254                                             *P* = 0.749
                                            CC         6     86.02          697.51                                                                                                                                                    
                             Non-drinking   TT         271   4284.35        632.53                                    1.144 (0.972--1.347)^[d](#tf15){ref-type="table-fn"}^   1.159 (0.960--1.399)^[d](#tf15){ref-type="table-fn"}^   1.233 (0.764--1.990)^[d](#tf15){ref-type="table-fn"}^
                                            TC         169   2460.48        686.86                                    *P* = 0.105                                             *P* = 0.126                                             *P* = 0.390
                                            CC         18    260.57         690.79                                                                                                                                                    
                 rs852423    Male           AA         119   1768.20        673.00                                    1.141 (0.952--1.368)^[a](#tf12){ref-type="table-fn"}^   1.334 (1.044--1.705)^[a](#tf12){ref-type="table-fn"}^   0.841 (0.536--1.320)^[a](#tf12){ref-type="table-fn"}^
                                            AG         126   1448.11        870.10                                    *P* = 0.153                                             *P* = 0.021                                             *P* = 0.451
                                            GG         21    366.50         572.99                                                                                                                                                    
                             Female         AA         171   2758.35        619.94                                    1.116 (0.948--1.315)^[a](#tf12){ref-type="table-fn"}^   1.056 (0.854--1.306)^[a](#tf12){ref-type="table-fn"}^   1.466 (1.038--2.068)^[a](#tf12){ref-type="table-fn"}^
                                            AG         137   2139.39        640.37                                    *P* = 0.188                                             *P* = 0.612                                             *P* = 0.030
                                            GG         38    508.40         747.44                                                                                                                                                    
                             \<55 years     AA         82    1859.30        441.03                                    1.261 (1.008--1.578)^[b](#tf13){ref-type="table-fn"}^   1.265 (0.941--1.701)^[b](#tf13){ref-type="table-fn"}^   1.581 (0.985--2.539)^[b](#tf13){ref-type="table-fn"}^
                                            AG         81    1503.42        538.77                                    *P* = 0.043                                             *P* = 0.120                                             *P* = 0.058
                                            GG         20    352.17         567.91                                                                                                                                                    
                                            GG         20    352.17         567.91                                                                                                                                                    
                             ≥ 55 years     AA         208   2667.25        779.83                                    1.072 (0.929--1.238)^[b](#tf13){ref-type="table-fn"}^   1.135 (0.938--1.373)^[b](#tf13){ref-type="table-fn"}^   0.984 (0.706--1.371)^[b](#tf13){ref-type="table-fn"}^
                                            AG         181   2084.08        868.49                                    *P* = 0.340                                             *P* = 1.135                                             *P* = 0.924
                                            GG         39    522.74         746.07                                                                                                                                                    
                             Smoking        AA         69    1138.23        606.20                                    1.155 (0.906--1.473)^[c](#tf14){ref-type="table-fn"}^   1.267 (0.919--1.746)^[c](#tf14){ref-type="table-fn"}^   1.212 (0.890--1.650)^[c](#tf14){ref-type="table-fn"}^
                                            AG         77    886.57         868.51                                    *P* = 0.246                                             *P* = 0.148                                             *P* = 0.222
                                            GG         13    210.41         617.84                                                                                                                                                    
                             Non-smoking    AA         221   3388.32        652.24                                    1.092 (0.948--1.259)^[c](#tf14){ref-type="table-fn"}^   1.088 (0.904--1.310)^[c](#tf14){ref-type="table-fn"}^   1.018 (0.572--1.814)^[c](#tf14){ref-type="table-fn"}^
                                            AG         186   2700.92        688.65                                    *P* = 0.222                                             *P* = 0.373                                             *P* = 0.951
                                            GG         46    664.49         692.26                                                                                                                                                    
                             Drinking       AA         65    973.00         668.04                                    1.208 (0.950--1.535)^[d](#tf15){ref-type="table-fn"}^   1.392 (0.999--1.940)^[d](#tf15){ref-type="table-fn"}^   1.036 (0.600--1.789)^[d](#tf15){ref-type="table-fn"}^
                                            AG         75    811.04         924.74                                    *P* = 0.124                                             *P* = 0.051                                             *P* = 0.898
                                            AG         75    811.04         924.74                                    *P* = 0.124                                             *P* = 0.051                                             *P* = 0.898
                             Non-drinking   AA         225   3559.53        632.11                                    1.099 (0.953--1.267)^[d](#tf15){ref-type="table-fn"}^   1.099 (0.914--1.322)^[d](#tf15){ref-type="table-fn"}^   1.216 (0.887--1.663)^[d](#tf15){ref-type="table-fn"}^
                                            AG         188   2776.46        677.12                                    *P* = 0.192                                             *P* = 0.316                                             *P* = 0.225
                                            GG         44    669.43         657.28                                                                                                                                                    
                 rs2966449   Male           TT         143   2002.44        714.13                                    1.072 (0.882--1.303)^[a](#tf12){ref-type="table-fn"}^   1.179 (0.923--1.506)^[a](#tf12){ref-type="table-fn"}^   0.769 (0.439--1.346)^[a](#tf12){ref-type="table-fn"}^
                                            TC         110   1343.78        818.59                                    *P* = 0.486                                             *P* = 0.187                                             *P* = 0.357
                                            CC         13    233.50         556.75                                                                                                                                                    
                             Female         TT         195   3040.83        641.27                                    1.000 (0.835--1.199)^[a](#tf12){ref-type="table-fn"}^   0.981 (0.792--1.215)^[a](#tf12){ref-type="table-fn"}^   1.110 (0.686--1.795)^[a](#tf12){ref-type="table-fn"}^
                                            TC         134   2052.30        652.93                                    *P* = 0.997                                             *P* = 0.861                                             *P* = 0.671
                                            CC         18    313.03         575.02                                                                                                                                                    
                             \<55 years     TT         103   2070.92        497.36                                    1.020 (0.797--1.307)^[b](#tf13){ref-type="table-fn"}^   1.010 (0.750--1.359)^[b](#tf13){ref-type="table-fn"}^   1.100 (0.576--2.102)^[b](#tf13){ref-type="table-fn"}^
                                            TC         70    1426.06        490.86                                    *P* = 0.873                                             *P* = 0.950                                             *P* = 0.772
                                            CC         10    209.84         476.55                                                                                                                                                    
                             ≥ 55 years     TT         235   2972.36        790.62                                    1.055 (0.903--1.233)^[b](#tf13){ref-type="table-fn"}^   1.122 (0.927--1.358)^[b](#tf13){ref-type="table-fn"}^   0.842 (0.542--1.308)^[b](#tf13){ref-type="table-fn"}^
                                            TC         174   1970.02        883.24                                    *P* = 0.501                                             *P* = 0.238                                             *P* = 0.444
                                            CC         21    336.69         623.72                                                                                                                                                    
                             Smoking        TT         85    1271.34        668.59                                    1.073 (0.825--1.395)^[c](#tf14){ref-type="table-fn"}^   1.152 (0.836--1.587)^[c](#tf14){ref-type="table-fn"}^   0.819 (0.378--1.775)^[c](#tf14){ref-type="table-fn"}^
                                            TC         67    837.37         800.12                                    *P* = 0.598                                             *P* = 0.387                                             *P* = 0.613
                                            CC         7     123.41         567.21                                                                                                                                                    
                             Non-smoking    TT         253   3771.93        670.74                                    0.999 (0.855--1.168)^[c](#tf14){ref-type="table-fn"}^   1.001 (0.831--1.207)^[c](#tf14){ref-type="table-fn"}^   0.988 (0.652--1.495)^[c](#tf14){ref-type="table-fn"}^
                                            TC         177   2558.71        691.75                                    *P* = 0.993                                             *P* = 0.988                                             *P* = 0.955
                                            CC         24    423.12         567.21                                                                                                                                                    
                             Drinking       TT         82    1094.57        749.15                                    1.080 (0.831--1.402)^[d](#tf15){ref-type="table-fn"}^   1.092 (0.786--1.516)^[d](#tf15){ref-type="table-fn"}^   1.128 (0.602--2.117)^[d](#tf15){ref-type="table-fn"}^
                                            TC         62    757.97         817.97                                    *P* = 0.566                                             *P* = 0.601                                             *P* = 0.707
                                            CC         11    137.20         801.75                                                                                                                                                    
                             Non-drinking   TT         256   3954.92        647.30                                    1.013 (0.867--1.184)^[d](#tf15){ref-type="table-fn"}^   1.049 (0.868--1.260)^[d](#tf15){ref-type="table-fn"}^   0.865 (0.551--1.358)^[d](#tf15){ref-type="table-fn"}^
                                            TC         182   2638.10        689.89                                    *P* = 0.870                                             *P* = 0.636                                             *P* = 0.529
                                            CC         20    409.32         488.62                                                                                                                                                    
  Stroke         rs852426    Male           TT         54    5271.40        102.44                                    0.908 (0.622--1.325)^[a](#tf12){ref-type="table-fn"}^   0.900 (0.583--1.387)^[a](#tf12){ref-type="table-fn"}^   0.860 (0.268--2.756)^[a](#tf12){ref-type="table-fn"}^
                                            TC         36    2981.01        120.76                                    *P* = 0.617                                             *P* = 0.632                                             *P* = 0.799
                                            CC         3     420.76         71.30                                                                                                                                                     
                             Female         TT         52    7670.07        67.80                                     1.287 (0.902--1.836)^[a](#tf12){ref-type="table-fn"}^   1.340 (0.870--2.064)^[a](#tf12){ref-type="table-fn"}^   1.442 (0.561--3.705)^[a](#tf12){ref-type="table-fn"}^
                                            TC         33    4393.60        75.11                                     *P* = 0.164                                             *P* = 0.184                                             *P* = 0.447
                                            CC         5     484.35         103.23                                                                                                                                                    
                             \<55 years     TT         7     4766.93        14.68                                     1.308 (0.406--4.214)^[b](#tf13){ref-type="table-fn"}^   1.603 (0.417--6.156)^[b](#tf13){ref-type="table-fn"}^   \-
                                            TC         5     2630.37        19.01                                     *P* = 0.653                                             *P* = 0.492                                             \-
                                            CC         0     313.26         \-                                                                                                                                                        
                             ≥ 55 years     TT         99    8174.54        121.11                                    1.059 (0.815--1.376)^[b](#tf13){ref-type="table-fn"}^   1.068 (0.783--1.456)^[b](#tf13){ref-type="table-fn"}^   1.086 (0.529--2.229)^[b](#tf13){ref-type="table-fn"}^
                                            TC         64    4744.24        134.90                                    *P* = 0.666                                             *P* = 0.679                                             *P* = 0.823
                                            CC         8     591.85         135.17                                                                                                                                                    
                             Smoking        TT         29    3202.08        90.57                                     0.734 (0.408--1.322)^[c](#tf14){ref-type="table-fn"}^   0.711 (0.369--1.372)^[c](#tf14){ref-type="table-fn"}^   0.627 (0.085--4.652)^[c](#tf14){ref-type="table-fn"}^
                                            TC         16    1824.74        87.68                                     *P* = 0.303                                             *P* = 0.309                                             *P* = 0.648
                                            CC         1     212.43         47.07                                                                                                                                                     
                             Non-smoking    TT         77    9739.39        79.06                                     1.167 (0.873--1.558)^[c](#tf14){ref-type="table-fn"}^   1.193 (0.843--1.689)c 1.241                             (0.573--2.686)^[c](#tf14){ref-type="table-fn"}^
                                            TC         53    5549.87        95.50                                     *P* = 0.296                                             *P* = 0.319                                             *P* = 0.584
                                            CC         7     692.68         101.06                                                                                                                                                    
                             Drinking       TT         29    2799.11        103.60                                    0.470 (0.227--0.975)^[d](#tf15){ref-type="table-fn"}^   0.473 (0.219--1.020)^[d](#tf15){ref-type="table-fn"}^   \-
                                            TC         11    1643.04        66.95                                     *P* = 0.042                                             *P* = 0.056                                             \-
                                            CC         0     233.57         \-                                                                                                                                                        
                             Non-drinking   TT         77    10142.37       75.92                                     1.278 (0.969--1.686)^[d](#tf15){ref-type="table-fn"}^   1.319 (0.943--1.847)^[d](#tf15){ref-type="table-fn"}^   1.448 (0.704--2.979)^[d](#tf15){ref-type="table-fn"}^
                                            TC         58    5731.56        101.19                                    *P* = 0.083                                             *P* = 0.106                                             *P* = 0.314
                                            CC         8     671.54         119.13                                                                                                                                                    
                                            CC         8     671.54         119.13                                                                                                                                                    
                 rs852423    Male           AA         41    4335.75        94.56                                     1.179 (0.856--1.624)^[a](#tf12){ref-type="table-fn"}^   1.304 (0.851--2.000)^[a](#tf12){ref-type="table-fn"}^   1.055 (0.505--2.203)^[a](#tf12){ref-type="table-fn"}^
                                            AG         44    3432.82        128.17                                    *P* = 0.313                                             *P* = 0.223                                             *P* = 0.884
                                            GG         8     898.40         89.05                                                                                                                                                     
                             Female         AA         42    6368.86        65.95                                     1.200 (0.884--1.628)^[a](#tf12){ref-type="table-fn"}^   1.314 (0.862--2.202)^[a](#tf12){ref-type="table-fn"}^   1.175 (0.600--2.300)^[a](#tf12){ref-type="table-fn"}^
                                            AG         38    4972.19        76.43                                     *P* = 0.243                                             *P* = 0.204                                             *P* = 0.638
                                            GG         10    1206.99        82.85                                                                                                                                                     
                             \<55 years     AA         6     3894.35        15.41                                     1.055 (0.364--3.057)^[b](#tf13){ref-type="table-fn"}^   1.543 (0.384--6.209)^[b](#tf13){ref-type="table-fn"}^   \-
                                            AG         6     3088.90        19.42                                     *P* = 0.921                                             *P* = 0.541                                             \-
                                            GG         0     721.09         \-                                                                                                                                                        
                             ≥ 55 years     AA         77    6810.25        113.06                                    1.182 (0.946--1.478)^[b](#tf13){ref-type="table-fn"}^   1.298 (0.956--1.763)^[b](#tf13){ref-type="table-fn"}^   1.120 (0.685--1.833)^[b](#tf13){ref-type="table-fn"}^
                                            AG         76    5316.10        142.96                                    *P* = 0.142                                             *P* = 0.095                                             *P* = 0.651
                                            GG         18    1384.29        130.03                                                                                                                                                    
                             Smoking        AA         22    2649.69        83.03                                     0.893 (0.549--1.454)^[c](#tf14){ref-type="table-fn"}^   0.977 (0.528--1.809)^[c](#tf14){ref-type="table-fn"}^   0.522 (0.125--2.177)^[c](#tf14){ref-type="table-fn"}^
                                            AG         22    2068.29        106.37                                    *P* = 0.650                                             *P* = 0.941                                             *P* = 0.372
                                            GG         2     515.05         38.83                                                                                                                                                     
                             Non-smoking    AA         61    8054.91        75.73                                     1.254 (0.978--1.607)^[c](#tf14){ref-type="table-fn"}^   1.370 (0.971--1.934)^[c](#tf14){ref-type="table-fn"}^   1.290 (0.762--2.184)^[c](#tf14){ref-type="table-fn"}^
                                            AG         60    6336.72        94.69                                     *P* = 0.074                                             *P* = 0.073                                             *P* = 0.342
                                            GG         16    1590.34        100.61                                                                                                                                                    
                             Drinking       AA         19    2269.49        83.72                                     1.192 (0.718--1.979)^[d](#tf15){ref-type="table-fn"}^   1.499 (0.760--2.955)^[d](#tf15){ref-type="table-fn"}^   0.669 (0.159--2.814)^[d](#tf15){ref-type="table-fn"}^
                                            AG         19    1893.11        100.36                                    *P* = 0.496                                             *P* = 0.242                                             *P* = 0.583
                                            GG         2     506.90         39.46                                                                                                                                                     
                             Non-drinking   AA         64    8435.11        75.87                                     1.207 (0.946--1.541)^[d](#tf15){ref-type="table-fn"}^   1.307 (0.934--1.829)^[d](#tf15){ref-type="table-fn"}^   1.218 (0.721--2.057)^[d](#tf15){ref-type="table-fn"}^
                                            AG         63    6511.89        96.75                                     *P* = 0.130                                             *P* = 0.119                                             *P* = 0.460
                                            GG         16    1598.48        100.10                                                                                                                                                    
                 rs2966449   Male           TT         46    4881.39        94.24                                     1.325 (0.945--1.859)^[a](#tf12){ref-type="table-fn"}^   1.436 (0.940--2.194)^[a](#tf12){ref-type="table-fn"}^   1.308 (0.561--3.051)^[a](#tf12){ref-type="table-fn"}^
                                            TC         41    3256.39        125.91                                    *P* = 0.103                                             *P* = 0.094                                             *P* = 0.534
                                            CC         6     529.21         113.38                                                                                                                                                    
                             Female         TT         52    7127.86        72.95                                     0.759 (0.521--1.104)^[a](#tf12){ref-type="table-fn"}^   0.794 (0.516--1.222)^[a](#tf12){ref-type="table-fn"}^   0.348 (0.083--1.464)^[a](#tf12){ref-type="table-fn"}^
                                            TC         36    4709.80        76.44                                     *P* = 0.149                                             *P* = 0.294                                             *P* = 0.150
                                            CC         2     710.40         28.15                                                                                                                                                     
                             \<55 years     TT         8     4438.70        18.02                                     0.706 (0.194--2.570)^[b](#tf13){ref-type="table-fn"}^   0.754 (0.186--3.050)^[b](#tf13){ref-type="table-fn"}^   \-
                                            TC         4     2828.25        14.14                                     *P* = 0.597                                             *P* = 0.692                                             \-
                                            CC         0     432.45         \-                                                                                                                                                        
                             ≥ 55 years     TT         90    7570.55        118.88                                    1.066 (0.828--1.371)^[b](#tf13){ref-type="table-fn"}^   1.131 (0.833--1.535)^[b](#tf13){ref-type="table-fn"}^   0.855 (0.417--1.755)^[b](#tf13){ref-type="table-fn"}^
                                            TC         73    5137.94        142.08                                    *P* = 0.620                                             *P* = 0.429                                             *P* = 0.670
                                            CC         8     807.16         99.11                                                                                                                                                     
                             Smoking        TT         27    2950.55        91.51                                     0.804 (0.461--1.400)^[c](#tf14){ref-type="table-fn"}^   0.810 (0.432--1.516)^[c](#tf14){ref-type="table-fn"}^   0.548 (0.074--4.076)^[c](#tf14){ref-type="table-fn"}^
                                            TC         18    2014.60        89.35                                     *P* = 0.441                                             *P* = 0.509                                             *P* = 0.557
                                            CC         1     267.90         37.33                                                                                                                                                     
                             Non-smoking    TT         71    9058.70        78.38                                     1.077 (0.813--1.428)^[c](#tf14){ref-type="table-fn"}^   1.143 (0.811--1.612)^[c](#tf14){ref-type="table-fn"}^   0.888 (0.408--1.933)^[c](#tf14){ref-type="table-fn"}^
                                            TC         59    5951.58        99.13                                     *P* = 0.605                                             *P* = 0.445                                             *P* = 0.765
                                            CC         7     971.71         72.04                                                                                                                                                     
                             Drinking       TT         26    2558.70        101.61                                    0.768 (0.419--1.408)^[d](#tf15){ref-type="table-fn"}^   0.853 (0.434--1.675)^[d](#tf15){ref-type="table-fn"}^   \-
                                            TC         14    1806.60        77.49                                     *P* = 0.394                                             *P* = 0.644                                             \-
                                            CC         0     310.42         \-                                                                                                                                                        
                             Non-drinking   TT         72    9450.55        76.19                                     1.096 (0.832--1.442)^[d](#tf15){ref-type="table-fn"}^   1.152 (0.823--1.612)^[d](#tf15){ref-type="table-fn"}^   0.969 (0.466--2.015)^[d](#tf15){ref-type="table-fn"}^
                                            TC         63    6159.58        102.28                                    *P* = 0.515                                             *P* = 0.410                                             *P* = 0.933
                                            CC         8     929.19         86.10                                                                                                                                                     

Adjusted for age, BMI, HDL-C, LDL-C, TC, TG, smoking status, drinking status and T2DM.

Adjusted for gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, drinking status and T2DM.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, drinking status and T2DM.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status and T2DM.

Adjusted for age, BMI, HDL-C, LDL-C, TC, TG, smoking status, drinking status, T2DM and hypertension.

Adjusted for gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, drinking status, T2DM and hypertension.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, drinking status, T2DM and hypertension.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, T2DM and hypertension

###### Stratification analyses of rs852426 with hypertension and stroke in the follow-up study

  End point      Stratum        Genotype   *N*   Person-years   Incidence density (/10^4^ Person-years)   HR (95% CI)                                                                                                   
  -------------- -------------- ---------- ----- -------------- ----------------------------------------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  Hypertension   Drinking       TT         86    1193.82        720.38                                    1.123 (0.848--1.487)[\*](#tf1){ref-type="table-fn"}    1.205 (0.863.1.683)[\*](#tf1){ref-type="table-fn"}     0.863 (0.371.2.007)[\*](#tf1){ref-type="table-fn"}
                                TC         63    709.91         887.44                                    *p* = 0.418                                            *p* = 0.272                                            *p* = 0.733
                                CC         6     86.02          697.51                                                                                                                                                  
                 Non-drinking   TT         271   4284.35        632.53                                    1.147 (0.974.1.349)[\*](#tf1){ref-type="table-fn"}     1.162 (0.962.1.403)[\*](#tf1){ref-type="table-fn"}     1.236 (0.766.1.995)[\*](#tf1){ref-type="table-fn"}
                                TC         169   2460.48        686.86                                    *p* = 0.100                                            *p* = 0.119                                            *p* = 0.385
                                CC         18    260.57         690.79                                                                                                                                                  
  Stroke         Drinking       TT         29    2799.11        103.60                                    0.470 (0.227.0.975)^[\#](#tf2){ref-type="table-fn"}^   0.473 (0.219.1.021)^[\#](#tf2){ref-type="table-fn"}^   \-
                                TC         11    1643.04        66.95                                     *p* = 0.042                                            *p* = 0.057                                            \-
                                CC         0     233.57         \-                                                                                                                                                      
                 Non-drinking   TT         77    10142.37       75.92                                     1.278 (0.969.1.687)^[\#](#tf2){ref-type="table-fn"}^   1.320 (0.943.1.847)^[\#](#tf2){ref-type="table-fn"}^   1.449 (0.705.2.980)^[\#](#tf2){ref-type="table-fn"}^
                                TC         58    5731.56        101.19                                    *p* = 0.083                                            *p* = 0.106                                            *p* = 0.313
                                CC         8     671.54         119.13                                                                                                                                                  

HR, hazard ratio; CI, confidence interval

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status and T2DM.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, T2DM and hypertension.

The Interaction Analysis between *ACTB* rs852426 and Drinking
-------------------------------------------------------------

The analysis stratified by never, light-to-moderate drinking and heavy drinking status indicated that the rs852426 variation had a protective effect on stroke in subjects with the light-to-moderate or heavy drinking habit, the HRs (95% CIs) were 0.523 (0.174−1.571) and 0.485 (0.176−1.336), although the *p* values did not reach statistical significance (*p* values were 0.248 and 0.162). The association of rs852426 with stroke incidence mentioned above had no heterogeneity between light-to-moderate drinking and heavy drinking groups (*Q* = 0.010, *p* = 0.935). Thus, we combined light-to-moderate drinking and heavy drinking groups when we assessed the interaction between rs852426 and drinking.

It is observed that rs852426 significantly interacted with drinking in stroke incidence. The additive interaction analysis indicated that the rs852426 and drinking had a negative interaction; the RERI (95% CI) was −0.705(−1.377, −0.237), and the *p* value was 3.164×10^−3^. After being adjusted for covariates, the interaction was still sound; the RERI (95% CI) was −0.907 (−1.411, −0.404) with a *p* value of 4.108×10^−4^. The multiplicative interaction was still sound, the HR (95% CI) for the multiplicative interaction term was 0.541 (0.291, 0.988), with *p* = 0.048. The detailed results are displayed in **[Table 3](#T3){ref-type="table"}**.

###### Association of rs852426 and drinking with stroke in the follow-up study

  Interaction                         Model 1                   Model 2
  --------------------- ------------- ------------------------- -------------------------
  Drinking\* rs852426                                           
                        HR (95% CI)   0.618 (0.349, 1.093)      0.541 (0.291, 0.994)
                        *p*           0.098                     0.048
  Drinking+rs852426                                             
  RERI                  HR (95% CI)   −0.705 (−1.377, −0.237)   −0.907 (−1.411, −0.404)
                        *p*           3.164×10^−3^              4.108×10^−4^
  AP                                  −0.994                    −1.398
  SI                                  0.704                     −0.630

HR, hazard ratio; CI, confidence interval; RERI, relative excess risk due to interaction; AP, attributable proportion due to interaction; SI, synergy index

Model 1 did not adjust any covariates.

Model 2 adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, T2DM and hypertension.

Validation of the Association of rs852426 and Alcohol Consumption with Stroke
-----------------------------------------------------------------------------

In the nested case-control study, the interaction between rs852426 additive model and alcohol consumption on stroke was further validated in Nantong population (**[Supplementary Table 8](#T12){ref-type="table"}**). Although the association of rs852426 and stroke did not reach statistical significance, significant additive interaction between drinking and rs852426 was observed in the nested case-control study. The RERI (95% CI) was −0.370 (−0.622, −0.118), with a *p* value of 3.945×10^−3^, and the OR (95% CI) was 0.749 (0.575−0.976), with a *p* value of 0.033 for the multiplicative interaction (**[Table 4](#T4){ref-type="table"}**).

###### Association analyses of rs852426 with stroke in the nested case-control study

  Stratification     Group     WT/HT/MT       *OR (95% CI)*                                                                                                   
  ------------------ --------- -------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  Total Population             TT/TC/CC                                                                                                                       
                     Case      537/280/43     0.996 (0.859--1.154)^[a](#tf20){ref-type="table-fn"}^   1.040 (0.865--1.250)^[a](#tf20){ref-type="table-fn"}^   0.821 (0.555--1.215)^[a](#tf20){ref-type="table-fn"}^
                     Control   1232/598/130   *P* = 0.958^[a](#tf20){ref-type="table-fn"}^            *P* = 0.678                                             *P* = 0.324
  Drinking                     TT/TC/CC                                                                                                                       
                     Case      155/65/9       0.801 (0.591--1.087)^[b](#tf21){ref-type="table-fn"}^   0.807 (0.557--1.168)^[b](#tf21){ref-type="table-fn"}^   0.560 (0.236--1.327)^[b](#tf21){ref-type="table-fn"}^
                     Control   352/195/36     *P* = 0.154^[b](#tf21){ref-type="table-fn"}^            *P* = 0.255                                             *P* = 0.188
  Non-drinking                 TT/TC/CC                                                                                                                       
                     Case      383/214/34     1.080 (0.910--1.281)^[b](#tf21){ref-type="table-fn"}^   1.150 (0.927--1.427)^[b](#tf21){ref-type="table-fn"}^   0.926 (0.593--1.446)^[b](#tf21){ref-type="table-fn"}^
                     Control   880/403/94     *P* = 0.380^[b](#tf21){ref-type="table-fn"}^            *P* = 0.204                                             *P* = 0.735

WT, wild type; HT, heterozygote; MT, mutant type; OR, odds ratio; CI, interval confidence.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, drinking status, T2DM and hypertension.

Adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, T2DM and hypertension.

###### Association of rs852426 and drinking with stroke in the nested case-control study

  Interaction                         Model 1                   Model 2
  --------------------- ------------- ------------------------- -------------------------
  Drinking\* rs852426                                           
                        HR (95% CI)   0.721 (0.568, 0.915)      0.749 (0.575, 0.976)
                        *p*           0.007                     0.033
  Drinking+rs852426                                             
  RERI                  HR (95% CI)   −0.435 (−0.803, −0.066)   −0.370 (−0.622, −0.118)
                        *p*           0.021                     3.945×10^−3^
  AP                                  −0.589                    −0.509
  SI                                  −1.520                    −2.815

HR, hazard ratio; CI, interval confidence; RERI, relative excess risk due to interaction; AP, attributable proportion due to interaction; SI, synergy index

Model 1 did not adjust any covariates.

Model 2 adjusted for age, gender, BMI, HDL-C, LDL-C, TC, TG, smoking status, T2DM and hypertension.

Comparison of *ACTB* mRNA Relative Expression Level between IS Cases and Controls
---------------------------------------------------------------------------------

No significant difference of the *ACTB* mRNA relative expression level was observed between IS and controls (1.03 ± 0.28 vs. 1.1 ± 0.18, **[Supplementary Fig. 2](#F3){ref-type="fig"}**). A further stratified analysis by drinking status indicated that in the drinking population, the expression of *ACTB* in IS was significantly lower (0.99 ± 0.26) than that in the controls (1.13 ± 0.20), with a *p* value of 0.026 (**[Fig. 1](#F1){ref-type="fig"}**). However, there is no significant difference of the *ACTB* mRNA level among rs852426 genotypes in IS or in controls (data not provided).

![The comparison of *ACTB* mRNA expression between IS and controls\
No significant difference of *ACTB* mRNA was observed between IS and controls (1.03 ± 0.28 vs 1.1 ± 0.18, *P* = 0.105)](jat-27-226-g003){#F3}

![The comparison of *ACTB* mRNA relative expression between IS cases and controls stratified by drinking status\
The expression of *ACTB* in IS with a drinking habit was significantly lower (0.99 ± 0.26) than that in the controls (1.13 ± 0.20), with *p* = 0.026.](jat-27-226-g001){#F1}

Discussion
==========

The current study evaluated the associations of *ACTB* polymorphisms with hypertension and stroke. The key findings indicated that rs852426 polymorphisms were significantly associated with the effect of alcohol consumption on stroke incidence. In the drinking population, it was first observed that the expression of *ACTB* in IS was significantly down-regulated.

Alcohol consumption is mostly taken as one of the covariates in numerous genetic association studies; thus, the molecular mechanism behind the alcoholic effect on stroke is easily neglected. Our novel finding indicated that the expression of *ACTB* was significantly down-regulated in IS who had a drinking habit. This might speculate that a drug that can up-regulate of *ACTB* expression will be a novel treatment method for the drinking population.

As generally regarded as a constitutive house-keeping gene, *ACTB* is an optimal reference gene for the quantitative reverse transcription polymerase chain reaction (RT-PCR) studies^[@bib21])^. The obvious impact of alcohol on *ACTB* mRNA expression in IS dramatically indicates that selection of *ACTB* mRNA as a reference of a RT-PCR analysis for CVD may not be favorable.

Ongoing large GWAS have identified novel SNPs and pathogenic pathways^[@bib22])^, which could partly elucidate the mechanisms involved in the progression of stroke. The pathogenesis of stroke is affected by not only genetic factors but also interactions between genetics and environment risk factors (such as alcohol drinking, smoking, or physical activities). Light-to-moderate alcohol consumption has generally been accepted as a potential protective factor for stroke, whereas heavy alcohol consumption was recognized as a risk factor^[@bib23],\ [@bib24])^. Alcohol reduces thrombus formation by inhibiting platelet aggregation^[@bib25])^, antioxidant capacity and insulin sensitivity^[@bib26])^; nonetheless, the biochemical mechanisms behind the cardiovascular beneficial effects of alcohol are still not fully elucidated.

The mutual protective effect between *ACTB* rs852426 polymorphisms and alcohol consumption on stroke provides a novel explanation for alcohol consumption attenuating the risk of stroke. Meanwhile, this interaction was further validated in a nested case-control study. To our knowledge, this study firstly observed the significant interaction of *ACTB* rs852426 and alcohol consumption on stroke. However, no significant difference of the *ACTB* mRNA level among rs852426 genotypes was observed; thus, elucidating the underlying modification of alcohol on *ACTB* mRNA expression in IS would warrant further biological function research.

The protective effect of *ACTB* rs852426 T\>C variation on stroke incidence was observed both in the light-to-moderate and heavy drinking sub-population, although the *p* values did not reach statistical significance after multiple corrections. This could be explained by the limited stroke incidence in the follow- up study. The association of rs852426 with stroke has no heterogeneity between light-to-moderate and drinking heavy drinking groups. Given the universality of drinking in Chinese daily life, we may speculate that drinking is deprecated for the patients with the rs852426 TT genotype predisposed to stroke in clinic management.

A regional LD plot (<http://www.broadinstitute.org/mpg/snap/ldplot.php>) was depicted for rs852426 (**[Supplementary Fig. 3](#F4){ref-type="fig"}**). Four loci (rs2537620, rs852432, rs2966450 and rs852446) were estimated near rs852426 with high LD (r^2^\>0.8), thus suggesting that a fine mapping for this region would be warranted.

![The regional LD Plot for rs852426, rs2537620, rs852432, rs2966450, and rs852446 were estimated loci near rs852426 with high LD (*r*^2^\>0.8)](jat-27-226-g004){#F4}

Several limitations were presented in the current study. First, we selected candidate SNPs with the criteria of MAF ≥ 0.05 and could have missed the chance of evaluating rare variants at *ACTB* for hypertension and stroke. Second, all participants were from the south China Han population; thus, the subject diversity of varied cultures and lifestyles was limited. Third, the significance in results obtained was not consistent in follow-up studies. This may be attributed to the fact that the case-control studies have a larger sample size than the number of incident events in the follow-up studies. Fourth, the median follow-up time of this study is 5.01 years, and only 613 hypertensions and 183 stroke incidences were recorded. The cumulative effect of *ACTB* on hypertension and stroke incidence should to be further confirmed by large-scale studies.

Conclusion
==========

Our findings suggest that significant negative interaction between rs852426 and alcohol consumption could attenuate the stroke risk. The expression of *ACTB* in IS who had a drinking habit was significantly down-regulated compared to that in controls. It will be interesting to determine the potentially important role of alcohol consumption and *ACTB* polymorphisms in the prevention and treatment of stroke.
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